Ajanta Pharma Ltd is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra, India. The company is engaged in the development, manufacture and marketing of pharmaceutical and finished dosage formulations.
The company has a diversified product portfolio with over 1,000 products in various therapeutic segments such as cardiology, diabetology, gastroenterology, ophthalmology, urology, anti-infective, pain management, and others.
Ajanta Pharma’s products are marketed in over 60 countries including the US, Europe, Africa, Asia and South America. The company has a strong R&D pipeline with over 100 products in various stages of development.
Ajanta Pharma’s vision is to be a global leader in the generic pharmaceuticals industry. The company’s mission is to provide affordable and quality medicines for all.
Ajanta Pharma’s business strategy is focused on expanding its global footprint through organic and inorganic growth. The company is also focusing on increasing its R&D investments to bring more innovative products to the market.
Ajanta Pharma is well-positioned for growth in the coming years. The company’s strong product portfolio, growing global presence, and strong R&D pipeline offer a solid platform for future growth.